Journal
BRAIN BEHAVIOR AND IMMUNITY
Volume 101, Issue -, Pages 275-283Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbi.2022.01.006
Keywords
Nitric oxide; Genetics; Major depressive disorder; Bipolar disorder; Schizophrenia
Categories
Funding
- Deutsche Forschungsgemeinschaft [FR3420/2-1, FR3420/2-2]
- DAAD [91690211]
- Bundesministerium fur Bildung und Forschung (BMBF) [57348387, 57458932]
Ask authors/readers for more resources
Nitric oxide (NO) signaling has been studied in relation to mental illnesses, but its specific contribution remains unclear. This study investigated the association between peripheral NO concentration, specific diagnoses, and genetic variation in NO synthase (NOS) genes. The results showed that patients with schizophrenia had significantly higher peripheral NO metabolite concentrations compared to other groups. Additionally, carriers of the NOS1 VNTR1 short allele had increased NO concentrations, which remained significant even at discharge. The data also suggested that patients with unresolved depressive symptoms had higher NO concentrations, with a positive correlation between symptom severity and NO concentration.
Nitric oxide (NO) signalling has been implicated in the pathogenesis of several mental illnesses; however, its specific contribution remains unclear. We investigated whether peripheral NO concentration is associated with specific diagnoses, and whether there is a correlation with genetic variation in NO synthase (NOS) genes. We included 185 participants in the study; 52 healthy controls, 43 major depressive disorder (MDD) patients, 41 bipolar disorder (BPD) patients, and 49 schizophrenia (SCZ) patients. Clinical, genetic, and biochemical data were collected at admission to a psychiatric hospital and at discharge. Serum was used to quantify concentration of the stable NO metabolites nitrite and nitrate. Individuals were genotyped for the NOS1 exon 1f variable number of tandem repeats 1 (VNTR1) polymorphism, and single nucleotide polymorphisms (SNPs) in the NOS1, NOS1AP and NOS3 genes. At admission, SCZ patients were found to have significantly higher peripheral NO metabolite (NOx-) concentrations compared to healthy controls, MDD and BPD patients. NOS1 exon 1f VNTR1 short allele carriers were found to have significantly increased NOx- concentration. Moreover, this result was still significant in patients even at discharge. The data also revealed that patients who did not remit in their depressive symptoms had significantly increased NOx- concentration compared to remitters at discharge, supported by the finding of a significant positive correlation between depression symptom severity and NOx- concentration. Taken together, it is possible that elevated peripheral NOx- concentration is associated with increased severity of psychopathology, potentially due to NOS1 exon1f VNTR1 genotype. Our results further implicate NO signalling in mental illness pathogenesis, supporting its possible use as a peripheral biomarker, and imply that NOS genotype may play a significant role in regulating peripheral NOx- concentration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available